DRA-11463 - USA (Washington, DC) - Exploratory Clinical Neuroscience Research Service - Deadline June 16,2028

(1) Vendor needs to provide exploratory clinical neuroscience research service to the government authority located in Washington, DC• Investigation of individual differences in neural circuitry underpinning SUD–related behavior and outcomes, including studies to understand the neurobiology underlying important risk factors for drug use and addiction (e.g., stress reactivity)• The study of behavioral or cognitive processes (e.g., learning, memory, emotion), and their neurobiological mechanisms, as variables contributing to substance use initiation, escalation, maintenance, abstinence, or relapse• Characterization of transition points and stages in the development of SUDs, including the use of neurobiological signatures that predict transition to more compulsive patterns of intake• Behavioral and neurobiological phenotyping to characterize patterns associated with risk for and protection against SUD• Identification of neural circuitry and cognition that are malleable and potentially responsive to preventative interventions • Behavioral phenotyping that considers complex patterns or constellations of individual differences across multiple dimensions (e.g., cognitive processes, drug sensitivity, response to environmental stimuli including social stimuli, reward reactivity, punishment sensitivity)